Skip to main content
ISCO filings

Corporate insider profile

Paul V Maier Filing Activity

Latest reported as Corporate insider of International Stem Cell CORP (ISCO).

Purchase filings
0
Reported companies
2
Net open-market value
-$2,964,066.64
Latest transaction
Sep 11, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 11, 2026International Stem Cell CORP (ISCO)Corporate insiderSale32,802$0.32$10,497
Aug 28, 2026Eton Pharmaceuticals, Inc. (ETON)Corporate insiderSale50,000$59.07$2,953,570